S J Tsai |
Glycogen synthase kinase-3beta gene is associated with antidepressant treatment response in Chinese major depressive disorder |
2008 |
1 |
6500486 [pii]\r10.1038/sj.tpj.6500486 |
I Mateo |
Epistasis between tau phosphorylation regulating genes (CDK5R1 and GSK-3beta) and Alzheimer's disease risk. |
2009 |
10 |
10.1111/j.1600-0404.2008.01128.x |
Dong-Mei Zhao |
GSK3beta reduces risk of sporadic Parkinson's disease in ethnic Chinese |
2012 |
1 |
 |
Daniele Radaelli |
Gene–gene interaction of glycogen synthase kinase 3-β and serotonin transporter on human antidepressant response to sleep deprivation |
2012 |
6 |
10.1016/j.jad.2011.10.039 |
John B J Kwok |
GSK3B polymorphisms alter transcription and splicing in Parkinson's disease. |
2005 |
12 |
10.1002/ana.20691 |
Hui Tang |
GSK-3β Polymorphism Discriminates Bipolar Disorder and Schizophrenia: A Systematic Meta-Analysis. |
2013 |
2 |
10.1007/s12035-013-8414-x |
D Galimberti |
GSK3 beta genetic variability in patients with Multiple Sclerosis |
2011 |
1 |
 |
Yen-Feng Lin |
Glycogen synthase kinase 3β gene polymorphisms may be associated with bipolar I disorder and the therapeutic response to lithium. |
2013 |
1 |
10.1016/j.jad.2012.08.025 |
F Benedetti |
Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3-β activity. |
2010 |
5 |
10.1111/j.1601-183X.2010.00566.x |
S-J Tsai |
Glycogen synthase kinase-3beta gene is associated with antidepressant treatment response in Chinese major depressive disorder. |
2008 |
9 |
10.1038/sj.tpj.6500486 |
Cristina Lorenzi |
Lithium and GSK3-β Promoter Gene Variants Influence White Matter Microstructure in Bipolar Disorder |
2012 |
6 |
10.1038/npp.2012.172 |
I Mateo |
Epistasis between tau phosphorylation regulating genes (CDK5R1 and GSK-3beta) and Alzheimer's disease risk. |
2009 |
7 |
- |
Yongsheng Yuan |
The association between glycogen synthase kinase 3 beta (GSK3-β) polymorphisms and Parkinson's disease susceptibility: A meta-analysis. |
2013 |
1 |
 |
Daniela Galimberti |
GSK3β genetic variability in patients with Multiple Sclerosis. |
2011 |
1 |
10.1016/j.neulet.2011.04.024 |
Katrin Spinnler |
Role of glycogen synthase kinase 3 (GSK-3) in innate immune response of human immature dendritic cells to Aspergillus fumigatus. |
2010 |
5 |
- |
John B J Kwok |
GSK3B polymorphisms alter transcription and splicing in Parkinson's disease. |
2005 |
11 |
- |
E Jiménez |
Genetic variability at IMPA2, INPP1 and GSK3β increases the risk of suicidal behavior in bipolar patients. |
2013 |
2 |
10.1016/j.euroneuro.2013.01.007 |
F Benedetti |
Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3-beta activity |
2010 |
8 |
10.1111/j.1601-183X.2010.00566.x |
D Galimberti |
GSK3beta genetic variability in patients with Multiple Sclerosis |
2011 |
1 |
S0304-3940(11)00470-8 [pii]\r10.1016/j.neulet.2011.04.024 |
Francesco Benedetti |
Lithium and GSK3-β Promoter Gene Variants Influence White Matter Microstructure in Bipolar Disorder. |
2012 |
4 |
10.1038/npp.2012.172 |
Feng Bai |
Association of a GSK-3β Polymorphism with Brain Resting-State Function in Amnestic-Type Mild Cognitive Impairment. |
2012 |
1 |
10.3233/JAD-2012-120631 |
Kunal Ray |
Role of tau kinases (CDK5R1 and GSK3B) in Parkinson's disease: A study from India |
2012 |
4 |
10.1016/j.neurobiolaging.2010.10.016 |
Feng Bai |
Association of a GSK-3β polymorphism with brain resting-state function in amnestic-type mild cognitive impairment. |
2012 |
2 |
10.3233/JAD-2012-120631 |
Tsai S.-J. |
Glycogen synthase kinase-3beta gene is associated with antidepressant treatment response in Chinese major depressive disorder |
2008 |
4 |
 |
Katrin Spinnler |
Role of glycogen synthase kinase 3 (GSK-3) in innate immune response of human immature dendritic cells to Aspergillus fumigatus. |
2010 |
5 |
10.3109/13693780903420625 |
S-J Tsai |
Glycogen synthase kinase-3beta gene is associated with antidepressant treatment response in Chinese major depressive disorder |
2008 |
3 |
 |
Carol Dobson-Stone |
GSK3B and MAPT Polymorphisms Are Associated with Grey Matter and Intracranial Volume in Healthy Individuals. |
2013 |
1 |
10.1371/journal.pone.0071750 |
I Mateo |
Epistasis between tau phosphorylation regulating genes (CDK5R1 and GSK-3 beta) and Alzheimer's disease risk |
2009 |
1 |
10.1111/j.1600-0404.2008.01128.x |
Na Zhang |
Association analysis of GSK3B and MAPT polymorphisms with Alzheimer's disease in Han Chinese. |
2011 |
5 |
10.1016/j.brainres.2011.03.052 |
Kallirhoe Kalinderi |
GSK3β polymorphisms, MAPT H1 haplotype and Parkinson's disease in a Greek cohort. |
2011 |
1 |
10.1016/j.neurobiolaging.2009.05.007 |
Daniela Galimberti |
GSK3β genetic variability in patients with Multiple Sclerosis. |
2011 |
1 |
- |
H Tang |
GSK-3beta Polymorphism Discriminates Bipolar Disorder and Schizophrenia: A Systematic Meta-Analysis |
2013 |
1 |
10.1007/s12035-013-8414-x |
Na Zhang |
Association analysis of GSK3B and MAPT polymorphisms with Alzheimer's disease in Han Chinese. |
2011 |
5 |
- |
F Benedetti |
Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3-β activity. |
2010 |
9 |
- |
Benedetti F |
Gene-gene interaction of glycogen synthase kinase 3-beta and serotonin transporter on human antidepressant response to sleep deprivation |
2012 |
9 |
10.1016/j.jad.2011.10.039 |
F Benedetti |
Gene-gene interaction of glycogen synthase kinase 3-(beta) and serotonin transporter on human antidepressant response to sleep deprivation |
2012 |
6 |
S0165-0327(11)00688-4 [pii]\r10.1016/j.jad.2011.10.039 |
Dong-Mei Zhao |
GSK3beta reduces risk of sporadic Parkinson's disease in ethnic Chinese |
2012 |
1 |
- |
Kallirhoe Kalinderi |
GSK3β polymorphisms, MAPT H1 haplotype and Parkinson's disease in a Greek cohort. |
2011 |
1 |
- |